KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Net Margin (2016 - 2025)

Historic Net Margin for Eli Lilly (LLY) over the last 16 years, with Q3 2025 value amounting to 31.72%.

  • Eli Lilly's Net Margin rose 232300.0% to 31.72% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.99%, marking a year-over-year increase of 105000.0%. This contributed to the annual value of 23.51% for FY2024, which is 81500.0% up from last year.
  • According to the latest figures from Q3 2025, Eli Lilly's Net Margin is 31.72%, which was up 232300.0% from 36.38% recorded in Q2 2025.
  • Eli Lilly's Net Margin's 5-year high stood at 36.38% during Q2 2025, with a 5-year trough of 0.6% in Q3 2023.
  • In the last 5 years, Eli Lilly's Net Margin had a median value of 21.58% in 2021 and averaged 21.63%.
  • In the last 5 years, Eli Lilly's Net Margin plummeted by -215200bps in 2023 and then skyrocketed by 232300bps in 2025.
  • Eli Lilly's Net Margin (Quarter) stood at 21.58% in 2021, then grew by 23bps to 26.54% in 2022, then decreased by -12bps to 23.41% in 2023, then soared by 39bps to 32.59% in 2024, then decreased by -3bps to 31.72% in 2025.
  • Its Net Margin was 31.72% in Q3 2025, compared to 36.38% in Q2 2025 and 21.68% in Q1 2025.